If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,136.00    9.00 (0.80%)
Bid:
1,133.50
Ask:
1,134.00
Spread: 0.50 (0.044%)
Market Cap: £9.60b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

3 Feb 2021 17:00

RNS Number : 9242N
Smith & Nephew Plc
03 February 2021
 

SMITH & NEPHEW PLC

 

3 February 2021

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.

 

Smith & Nephew Global Share Plan 2010 (Performance Share Awards):

 

Name of PDMR

Number of ordinary shares under award granted on 07/03/2018 (shown at maximum)

Number of ordinary shares lapsed under award (shown at maximum)

Bradley Cannon

32,528

24,884

Phil Cowdy

15,494

11,853

Elga Lohler

24,768

18,948

Catheryn O'Rourke

24,548

18,780

Vasant Padmanabhan

27,894

21,339

Susan Swabey

10,920

8,354

 

Notes:

 

(i) Following completion of the performance measurement period, 47% of the target awards made on 7 March 2018 vested.

 

(ii) At maximum, 76.5% of awards have lapsed on 3 February 2021 and the remaining 23.5% of awards will vest and subject to continued employment, will be settled on 8 March 2021 being the first business date after the third anniversary of the awards.

 

This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.

 

Vickie Reuben

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0) 1923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFERFEIVIIL
Date   Source Headline
12th Feb 20257:11 amRNSBlock listing Interim Review
6th Feb 20257:00 amRNSNotice of Results
3rd Feb 202510:27 amRNSTotal Voting Rights
14th Jan 20257:00 amRNSDirectorate Change
2nd Jan 202512:51 pmRNSTotal Voting Rights
20th Dec 20249:46 amRNSDirector/PDMR Shareholding
16th Dec 202411:50 amRNSHolding(s) in Company
12th Dec 20249:53 amRNSHolding(s) in Company
11th Dec 20249:03 amRNSHolding(s) in Company
9th Dec 20243:00 pmRNSDirector/PDMR Shareholding
6th Dec 20247:00 amRNSDirector Share Award vest and sale to cover tax
5th Dec 20243:35 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSHolding(s) in Company
4th Dec 20248:43 amRNSHolding(s) in Company
2nd Dec 202411:30 amRNSTotal Voting Rights
12th Nov 20247:00 amRNSDirector/PDMR Shareholding
11th Nov 20244:45 pmRNSDirector/PDMR Shareholding
1st Nov 20243:44 pmRNSDirector/PDMR Shareholding
1st Nov 20242:30 pmRNSTotal Voting Rights
31st Oct 20247:00 amRNSSmith+Nephew Third Quarter 2024 Trading Report
24th Oct 20247:00 amRNSSterling Amount of Dividend
16th Oct 20247:00 amRNSNotice of Results
1st Oct 20243:44 pmRNSTotal Voting Rights
27th Sep 202412:23 pmRNSChange to Directors' Role and Responsibilities
24th Sep 20249:00 amRNSDirector/PDMR Shareholding
19th Sep 20243:50 pmRNSDirector/PDMR Shareholding
17th Sep 20242:27 pmRNSDirector/PDMR Shareholding
13th Sep 20243:16 pmRNSDirector/PDMR Shareholding
2nd Sep 20244:11 pmRNSTotal Voting Rights
30th Aug 202410:38 amRNSDirector/PDMR Shareholding
16th Aug 20249:32 amRNSDirector/PDMR Shareholding
14th Aug 20241:14 pmRNSDirector/PDMR Shareholding
14th Aug 202411:05 amRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSAdoption of Remuneration Policy and RSP
7th Aug 20247:00 amRNSDirector/PDMR Shareholding
5th Aug 202412:08 pmRNSBlock listing Interim Review
1st Aug 202411:09 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSHalf-year Report
12th Jul 20247:00 amRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSNotice of Results
4th Jul 20247:00 amRNSTR1: Notification of Major Holdings
3rd Jul 20247:00 amRNSTR1: Notification of Major Holdings
1st Jul 20244:22 pmRNSTotal Voting Rights
3rd Jun 20242:03 pmRNSTotal Voting Rights
30th May 20246:17 pmRNSDirector/PDMR Shareholding
24th May 20244:37 pmRNSDirector/PDMR Shareholding
22nd May 20244:23 pmRNSDirector/PDMR Shareholding
21st May 20249:52 amRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSDividend Declaration
8th May 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.